Rapamycin suppresses TLR4-triggered IL-6 and PGE2 production of colon cancer cells by inhibiting TLR4 expression and NF-κB activation
- Type
- Correction
- Notice date
- 5/17/2020 0:00
- Journal
- Molecular Immunology
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.molimm.2020.05.003
- Original paper DOI
- 10.1016/j.molimm.2008.01.025